George Margaritopoulos

2.4k total citations
47 papers, 1.2k citations indexed

About

George Margaritopoulos is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, George Margaritopoulos has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 19 papers in Physiology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in George Margaritopoulos's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42 papers), Sarcoidosis and Beryllium Toxicity Research (14 papers) and Medical Imaging and Pathology Studies (10 papers). George Margaritopoulos is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42 papers), Sarcoidosis and Beryllium Toxicity Research (14 papers) and Medical Imaging and Pathology Studies (10 papers). George Margaritopoulos collaborates with scholars based in Greece, United Kingdom and Italy. George Margaritopoulos's co-authors include Κατερίνα Αντωνίου, Athol U. Wells, Eirini Vasarmidi, Venerino Poletti, Francesco Bonella, Nikolaos M. Siafakas, Sara Tomassetti, Nikos M. Siafakas, Katerina Samara and Eliza Tsitoura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and European Respiratory Journal.

In The Last Decade

George Margaritopoulos

46 papers receiving 1.2k citations

Peers

Countries citing papers authored by George Margaritopoulos

Since Specialization

Citations

This map shows the geographic impact of George Margaritopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Margaritopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Margaritopoulos more than expected).

Fields of papers citing papers by George Margaritopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Margaritopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Margaritopoulos. The network helps show where George Margaritopoulos may publish in the future.

Co-authorship network of co-authors of George Margaritopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of George Margaritopoulos. A scholar is included among the top collaborators of George Margaritopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Margaritopoulos. George Margaritopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment Response and Safety Profile of Nintedanib in Connective Tissue Disease-Associated Interstitial Lung Disease: A Retrospective Observational Study 2025 ·Mediterranean Journal of Rheumatology ·(unknown), (unknown), (unknown), (unknown), Maria Mytilinaiou, (unknown), George Margaritopoulos, Dimitrios P. Bogdanos, Theodoros Dimitroulas, Theodora Simopoulou	0
2	“Regression to the truth”: lessons learned from negative IPF trials 2025 ·Breathe ·Athina Trachalaki, Anna Lindahl, (unknown), George Margaritopoulos	1
3	Imaging in the diagnosis and management of fibrosing interstitial lung diseases 2024 ·Breathe ·(unknown), (unknown), Ádám Domonkos Tárnoki, Dávid László Tárnoki, George Margaritopoulos, Helmut Prosch	6
4	Recent advances in the treatment of systemic sclerosis associated interstitial lung disease 2023 ·Frontiers in Medicine ·(unknown), Αrgyris Τzouvelekis, George Margaritopoulos	5
5	Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis 2022 ·Respirology ·Claudio Macaluso, Cristina Boccabella, Maria Kokosi, (unknown), Vasileios Kouranos, Peter M. George, George Margaritopoulos, Philip L. Molyneaux, Felix Chua, Toby M. Maher, Gísli Jenkins, Andrew G. Nicholson, Sujal R. Desai, Anand Devaraj, Athol U. Wells, Elisabetta Renzoni, Carmel Stock	12
6	Bilateral mediastinal lymphadenopathy with cough and shortness of breath 2022 ·Breathe ·(unknown), (unknown), Gillian Bain, Patrizia Viola, George Margaritopoulos	1
7	Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality 2021 ·Frontiers in Immunology ·Eliza Tsitoura, Athina Trachalaki, Eirini Vasarmidi, (unknown), George Margaritopoulos, Maria Kokosi, (unknown), (unknown), Vassilis Aidinis, (unknown), Nikos Tzanakis, Athol U. Wells, Κατερίνα Αντωνίου	22
8	Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression 2020 ·Respirology ·Carmel Stock, Rachel K. Hoyles, Cécile Daccord, Maria Kokosi, Dina Visca, Angelo De Lauretis, Veronica Alfieri, Vasileios Kouranos, George Margaritopoulos, Peter M. George, Philip L. Molyneaux, Felix Chua, Toby M. Maher, David Abraham, Voon H Ong, Jackie Donovan, Piersante Sestini, Christopher P. Denton, Athol U. Wells, Elisabetta Renzoni	35
9	Image of the month: Placental transmogrification of the lung: a rare cause of cystic lung disease 2020 ·Clinical Medicine ·Dalia Mudawi, (unknown), (unknown), Melanie Greaves, George Margaritopoulos	1
10	Defining genetic risk factors for scleroderma-associated interstitial lung disease 2020 ·Clinical Rheumatology ·Carmel Stock, Angelo De Lauretis, Dina Visca, Cécile Daccord, Maria Kokosi, Vasileios Kouranos, George Margaritopoulos, Peter M. George, Philip L. Molyneaux, Svetlana I. Nihtyanova, Felix Chua, Toby M. Maher, Voon H Ong, David Abraham, Christopher P. Denton, Athol U. Wells, Louise V. Wain, Elisabetta Renzoni	19
11	Pirfenidone improves survival in IPF: results from a real-life study 2018 ·BMC Pulmonary Medicine ·George Margaritopoulos, Athina Trachalaki, Athol U. Wells, Eirini Vasarmidi, Eleni Bibaki, (unknown), (unknown), Nikos Tzanakis, Κατερίνα Αντωνίου	71
12	Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis 2017 ·Respiratory Research ·Katerina Samara, Athina Trachalaki, Eliza Tsitoura, Anastasios Koutsopoulos, Eleni Lagoudaki, Ismini Lasithiotaki, George Margaritopoulos, Panagiotis Pantelidis, Eleni Bibaki, Nikolaos M. Siafakas, Νikolaos Tzanakis, Athol U. Wells, Κατερίνα Αντωνίου	48
13	Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy 2016 ·PubMed ·George Margaritopoulos, Eirini Vasarmidi, Κατερίνα Αντωνίου	62
14	Toll-like receptors and autophagy in interstitial lung diseases 2016 ·European Journal of Pharmacology ·George Margaritopoulos, Ismini Lasithiotaki, Κατερίνα Αντωνίου	8
15	009. Evaluation of respiratory symptoms in the emergency department 2015 ·Journal of Thoracic Disease ·(unknown), (unknown), (unknown), George Margaritopoulos, (unknown), (unknown), (unknown), (unknown), (unknown)	1
16	Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night 2015 ·European Respiratory Review ·Sophia E. Schiza, Charalampos Mermigkis, George Margaritopoulos, (unknown), Sergio Harari, Venerino Poletti, Elisabetta Renzoni, Olga Torre, Dina Visca, (unknown), George Sourvinos, Κατερίνα Αντωνίου	45
17	Interstitial lung disease 2014 ·European Respiratory Review ·Κατερίνα Αντωνίου, George Margaritopoulos, Sara Tomassetti, Francesco Bonella, (unknown), Venerino Poletti	174
18	Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema 2013 ·BMC Pulmonary Medicine ·Αrgyris Τzouvelekis, (unknown), Anastasia Oikonomou, Dimitrios Mikroulis, George Margaritopoulos, Anastasios Koutsopoulos, Antonis Ántoniadis, (unknown), Paschalis Steiropoulos, (unknown), (unknown), Μarios E. Froudarakis, Demosthenes Bouros	37
19	The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications 2009 ·Experimental and Therapeutic Medicine ·Foteini Economidou, George Margaritopoulos, Κατερίνα Αντωνίου, Nikolaos M. Siafakas	23
20	Different Activity of the Biological Axis VEGF-Flt-1 (fms-Like Tyrosine Kinase 1) and CXC Chemokines between Pulmonary Sarcoidosis and Idiopathic Pulmonary Fibrosis: A Bronchoalveolar Lavage Study 2009 ·SHILAP Revista de lepidopterología ·Κατερίνα Αντωνίου, Giannoula Soufla, (unknown), George Margaritopoulos, (unknown), (unknown), Katerina Samara, Demetrios�� Spandidos, Nikolaos M. Siafakas	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact